card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Significant Developments, Trends and Approaches in Next Generation Flow Cytometry

Q&A with Mark Edinger
Home / Insights / Significant Developments, Trends and Approaches in Next Generation Flow Cytometry

Flow cytometry has gone through many changes in the past decades, and it continues to gain greater utility in drug development testing for pharmaceutical and biotechnology companies. The usage of flow cytometry has had recent advances in complexity, including flow cytometry instrument designs, reagents, and analysis algorithms.

Mark Edinger, scientific affairs director of flow cytometry, was interviewed by Applied Clinical Trials, where he discussed trends in next generation flow cytometry. Read the article to learn how flow cytometry has become a central part of the development of new immunotherapies, and how next generation flow cytometry will become an even more essential tool in discovery as it continues to expand its capability and utility.


Download Document